NCT03358849 2019-01-16Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract CancerYonsei UniversityPhase 1 Completed9 enrolled